IHA is at the center of healthcare advocacy in Washington, D.C. Our efforts focus on legislation in Congress and policy proposals within federal regulatory agencies to advance healthcare in Illinois.
Contact your U.S. Representative now and ask him/her to sign the Roskam-Thompson letter on OPPS site-neutral cuts.
This memo summarizes legislation passed by the U.S. House to address the opioid crisis.
IHA has strong concerns about proposed changes to Methods for Assuring Access to Medicaid Services-Exemptions for States with High Managed Care Penetration Rates and Rate Reduction Threshold.
IHA urges the Centers for Medicare & Medicaid Services to approve the Illinois Hospital Assessment Program redesign to preserve access to care for Illinois Medicaid beneficiaries.
The Illinois Congressional Delegation urges CMS to expeditiously review and approve Illinois state plan amendments, which include reforms to modernize the state’s Hospital Assessment Program.
Materials designed to guide you through IHA’s activities during the meeting, including our Federal Advocacy Day on May 8.
IHA asks the Illinois Congressional Delegation to urge the Centers for Medicare & Medicaid Services to review and approve the State Plan Amendments for the redesigned Hospital Assessment Program.
Use IHA’s talking points in your advocacy for the 340B Drug Pricing Program, which allows certain hospitals to offer affordable prescription drugs to financially vulnerable and fragile patients.
In a letter to U.S. senators, IHA provided requested input on healthcare price transparency and shared Illinois’ progress on offering patients relevant and meaningful price information.
The Rural Hospital Access Act (H.R. 1955/S. 872) would make permanent the Medicare-dependent Hospital and enhanced Low-volume Adjustment programs. Urge Congress to support it.
Ask your U.S. Representative to co-sponsor H.R. 4392 to protect the 340B Drug Pricing Program from a 30 percent pay reduction that could cost hospitals $1.6 billion.
IHA supports preserving the tax exemption for private activity bonds, which are a vital source of affordable financing that enables non-profit hospitals to make investments in their facilities.
Urge Congress to support Rural Medicare Extenders. Funding for the Medicare-dependent hospital and enhanced low-volume adjustment programs expires Sept. 30, 2017.
CMS seeks input on concerns about current Physician Self-Referral law; deadline is Aug. 24
IHA urges Congress to require Medicare Administrative Contractors to extend the site-neutral exception opportunity to those HOPDs that relocated after Nov. 2, 2015.
IHA urges Congress to support the Resident Physician Shortage Reduction Act (H.R. 2267/S. 1301) and prevent cuts and overly burdensome regulations to the Medicare Graduate Medical Education program.
IHA’s position paper on the 340B Drug Pricing Program outlines why the program is critical to patients and hospitals and the specific actions Congress can take to protect it.
Illinois receives less federal funding per Medicaid beneficiary than any other state and has one of the lowest Medicaid matching rates in the country.
U.S. Reps. Michael Bost, Rodney Davis and Randy Hultgren from Illinois signed a letter in support of maintaining tax-exempt status for private activity bonds in the final tax reform bill.
See IHA's talking points on the Inpatient Prospective Payment System proposed rule on the phase-in of Worksheet S-10 data for uncompensated care that hospitals provide beginning in FFY 2018.
IHA supported the Drug-price Transparency in Communications Act to address recent dramatic increases in prices for generic and specialty prescription drugs.
Illinois Sens. Richard J. Durbin and Tammy Duckworth, along with a majority of U.S. senators, urged federal officials to protect the 340B Drug Pricing Program.
Fifteen U.S. representatives from Illinois joined a majority of House members in asking federal officials to abandon proposed changes to the 340B Drug Pricing Program.
Learn more about Illinois' 223 hospitals, which together have 1.5 million inpatient admissions and 38 million outpatients visits a year.
Pharmaceutical manufacturers participating in Medicaid must discount outpatient drugs to qualifying hospitals and other providers who see a large number of low-income patients and rural populations.
IHA looked at lost spending, econmic impacts and Medicare cuts by Congressional District in our preliminary estimates of repealing the Affordable Care Act without a replacement plan.